Skip to main content
Home
Online First
Articles
Latest Issue
Issue Archive
Special Issues
Supplements
Categories
Conference Correspondent
ASH 2023 - CLL
SABCS 2023 - HR+/HER2- MBC
Web Exclusives
All Web Exclusives
Interview with the Innovators
Rapid Reactions
FDA Oncology Update
Videos
Press Releases
Gastrointestinal Cancer Monthly Minutes
For Authors
Author Guidelines
Symptom Management Overview
Letters to the Editor Instructions
Join Our Peer Review
Submit a Manuscript
About
About JHOP
Contact Us
Editorial Policies
Peer-Review Process
About the Editors
Editorial Board
Editorial Process
Advertising Policy
Advertise
Subscribe
Home
Online First
Articles
Latest Issue
Issue Archive
Special Issues
Supplements
Categories
Conference Correspondent
ASH 2023 - CLL
SABCS 2023 - HR+/HER2- MBC
Web Exclusives
All Web Exclusives
Interview with the Innovators
Rapid Reactions
FDA Oncology Update
Videos
Press Releases
Gastrointestinal Cancer Monthly Minutes
For Authors
Author Guidelines
Symptom Management Overview
Letters to the Editor Instructions
Join Our Peer Review
Submit a Manuscript
About
About JHOP
Contact Us
Editorial Policies
Peer-Review Process
About the Editors
Editorial Board
Editorial Process
Advertising Policy
Advertise
FDA Oncology Update
Lung Cancer
,
FDA Oncology Update
FDA Approves Tecentriq plus Chemotherapy for First-Line Treatment of Extensive-Stage Small-Cell Lung Cancer
Yvette Florio Lane
Read More
FDA Oncology Update
FDA Approves Tecentriq plus Abraxane—First Immunotherapy for PD-L1– Positive Unresectable Locally Advanced or Metastatic Triple-Negative Breast Cancer
Yvette Florio Lane
Read More
FDA Oncology Update
March 08, 2019 – FDA Approvals, News & Updates
Yvette Florio Lane
Read More
FDA Oncology Update
FDA Approves Pembrolizumab for Treatment of Advanced Melanoma
Yvette Florio Lane
Read More
FDA Oncology Update
FDA Approves Split-Dosing Regimen for Daratumumab in Patients with Multiple Myeloma
Yvette Florio Lane
Read More
FDA Oncology Update
February 8, 2019 - FDA Approvals, News & Updates
Yvette Florio Lane
Read More
FDA Oncology Update
February 1, 2019 - FDA Approvals, News & Updates
Yvette Florio Lane
Read More
FDA Oncology Update
Government Shutdown Impacts FDA Drug Approvals
Yvette Florio Lane
Read More
FDA Oncology Update
Braftovi Plus Mektovi a New Combination for Unresectable or Metastatic Melanoma with BRAF Mutation
Read More
FDA Oncology Update
Lenvima Now Approved for Unresectable Hepatocellular Carcinoma
Read More
4
5
6
7
8
9
10
Page 7 of 13
Results 61 - 70 of 121